Back to 
Fuller & Thaler Asset Management, Inc.
Fuller & Thaler Asset Management, Inc.
LGND
2 quarters
Position history for Fuller & Thaler Asset Management, Inc.'s holdings in Ligand Pharmaceuticals Incorporated
No. Fuller & Thaler Asset Management exited its LGND (Ligand Pharmaceuticals) position in Q1 2019. Its Q4 2018 13F listed 44,640 shares worth $6.1M. Fuller & Thaler Asset Management already held LGND in its Q4 2018 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Final Value
$0
Final Shares
0
Total Value Change
-$6.1M
Total Shares Change
-44,640
Quarter-by-Quarter History
Other major holders of LGND: BlackRock, Inc., Vanguard Group Inc.